Literature DB >> 12943157

Cystic fibrosis mutations in Costa Rica.

Patricia B Venegas1, Jessica M Novak, Castro A Oscar, Félix L Sánchez, Inés G Gutiérrez, Julio M Rivera, Jorge P Salas, Jenny F Montero, Wayne W Grody.   

Abstract

Using polymerase chain reaction amplification of DNA in dried blood spots and a nonisotopic reverse dot blot hybridization method, we performed molecular genetic analysis for 6 and for 16 of the most common mutations of the cystic fibrosis transmembrane conductance regulator gene (CFTR) in 24 unrelated Costa Rican individuals with cystic fibrosis (CF). While many countries and ethnic groups have been surveyed for CF mutations since the cloning of CFTR, Costa Rica has not heretofore been studied. Moreover, Costa Rica represents an especially intriguing population because of its mixed European-African-Amerindian origins and the existence of a detailed historical record of the founding Spanish families. Thus, such a study may reveal not only the population frequencies of various mutant alleles in this country, but also something about their geographic migrations and ethnic founder effects. The most common CF mutation in Caucasians, deltaF508, was found in only 11 (23%) of the CF chromosomes studied, while the G542X mutation, relatively rare in the general population but more common in southern Europe, was observed in 12 (25%). None of the other mutations tested was found in any of the subjects. We failed to detect the second mutant allele in 17 subjects and could not detect either allele in 4 subjects. The high prevalence of the G542X mutation in our cohort, which exceeds that of both the general Caucasian population and the American Hispanic population, reflects the strong genetic influence of the original Spanish founding families of Costa Rica. These results highlight important differences in Costa Rican CF genotypes as compared both to other North American and European populations and to American Hispanics, raising important implications about isolated founder effects and strategies for population screening in that country.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12943157     DOI: 10.1353/hub.2003.0039

Source DB:  PubMed          Journal:  Hum Biol        ISSN: 0018-7143            Impact factor:   0.553


  3 in total

Review 1.  Pharmacogenetic research activity in Central America and the Caribbean: a systematic review.

Authors:  Carolina Céspedes-Garro; María-Eugenia G Naranjo; Fernanda Rodrigues-Soares; Adrián LLerena; Jorge Duconge; Lazara K Montané-Jaime; Hilda Roblejo; Humberto Fariñas; María de Los A Campos; Ronald Ramírez; Víctor Serrano; Carmen I Villagrán; Eva M Peñas-LLedó
Journal:  Pharmacogenomics       Date:  2016-09-16       Impact factor: 2.533

2.  Analysis of CFTR Gene Mutations in Children with Cystic Fibrosis, First Report from North-East of Iran.

Authors:  Atieh Mehdizadeh Hakkak; Mohammad Keramatipour; Saeid Talebi; Azam Brook; Jalil Tavakol Afshari; Amin Raazi; Hamid Reza Kianifar
Journal:  Iran J Basic Med Sci       Date:  2013-08       Impact factor: 2.699

3.  Wilson disease in Costa Rica: Pediatric phenotype and genotype characterization.

Authors:  Monica Penon-Portmann; Stephanie Lotz-Esquivel; Alejandra Chavez Carrera; Mildred Jiménez-Hernández; Danny Alvarado-Romero; Sharon Segura-Cordero; Fiorella Rimolo-Donadio; Francisco Hevia-Urrutia; Alfredo Mora-Guevara; Manuel Saborío-Rocafort; Gabriela Jiménez-Arguedas; Ramsés Badilla-Porras
Journal:  JIMD Rep       Date:  2020-02-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.